Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

The Increasing Number of Therapeutic Drugs, Need for Immediate Relief Drive the Growth of Parenteral and Transdermal Excipients

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.

Table of Contents

Executive SummaryExecutive SummaryResearch Scope and MethodologyMarket OverviewMarket Overview—Parenteral ExcipientsMarket Overview—Transdermal ExcipientsMarket Overview—Parenteral Excipient Types/ClassificationMarket Overview—Parenteral Excipient FunctionsMarket Overview—Transdermal Excipient Types/ ClassificationMarket Overview—Transdermal Excipients FunctionsAdvancement in Liquid Dosage Excipients—Value ChainTotal Transdermal and Parenteral Market—Drivers and RestraintsParenteral Excipients Segment—Drivers and RestraintsDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued) Restraints ExplainedTransdermal Excipients Segment—Drivers and RestraintsDrivers ExplainedDrivers Explained (continued)Restraints ExplainedTotal Transdermal and Parenteral Market—Forecast and TrendsMarket Engineering MeasurementsTotal Transdermal and Parenteral Excipients Market—Revenue and Volume ForecastRevenue and Volume Forecast DiscussionParenteral Excipients Segment—Pricing by Product TypeParenteral Excipients Segment—Pricing by Product Type (continued)Transdermal Excipients Segment—Pricing by Product TypeTransdermal Excipients Segment—Pricing by Product Type (continued)Transdermal and Parenteral Excipients Market—Pricing by Product Type DiscussionCompetitive AnalysisExcipients for Parenteral Products—SuppliersExcipients for Parenteral Products—Suppliers (continued)Excipients for Transdermal Products—Suppliers Market Share Analysis—Ranking of Suppliers for Selected ExcipientsCompetitive Analysis—Excipients in Marketed Parenteral ProductsCompetitive Analysis—Excipients in Marketed Parenteral Products (continued)Competitive Analysis—Excipients in Marketed Parenteral Products (continued)Competitive Analysis—Excipients in Marketed Transdermal Products—Technology OverviewCompetitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview (continued)Transdermal and Parenteral Excipients Market—Competitive Factors Transdermal and Parenteral Excipients Market—Competitive Factors DiscussionTransdermal and Parenteral Excipients Market—Competitive Factors Discussions (continued) Company Profile of Key Market Participants—BASFCompany Profile of Key Market Participants—BASF (continued)Company Profile of Key Market Participants—Dow Chemicals Company Profile of Key Market Participants—Dow Chemicals (continued)Company Profile of Key Market Participants—GattefosseCompany Profile of Key Market Participants—Gattefosse (continued)Segment Breakdown—Parenteral ExcipientsParenteral Excipients Segment Breakdown Excipients for Parenteral ProductsExcipients for Parenteral Products—Technology OverviewExcipients for Parenteral Products—Technology Overview (continued)Parenteral Excipients Segment—Market Engineering MeasurementParenteral Excipients Segment—Revenue and Volume ForecastRevenue and Volume Forecast DiscussionParenteral Excipients Segment—Percent Volume by Excipient TypePercent Volume by Excipient Type DiscussionPercent Volume by Excipient Type Discussion (continued)Segment Breakdown—Transdermal ExcipientsTransdermal Excipients Segment Breakdown Excipients for Transdermal Products—Technology OverviewExcipients for Transdermal Products—Technology Overview (continued)Excipients for Transdermal Products—Technology Overview (continued)Market Engineering Measurements—Transdermal Excipients SegmentTransdermal Excipients Segment—Revenue and Volume ForecastRevenue and Volume Forecast DiscussionTransdermal Excipients Segment—Percent Volume by Excipient TypePercent Volume by Excipient Type DiscussionPercent Volume by Excipient Type Discussion (continued)Regional Breakdown—Transdermal and Parenteral Excipients MarketTransdermal and Parenteral Excipients Market—Regional BreakdownTransdermal and Parenteral Excipients Market—Regional Breakdown DiscussionLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 03-Jan-17

Region : North America

Release Date : 11-Oct-16

Region : North America

Release Date : 22-Sep-16

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.